Zydus Lifesciences' (NSE:ZYDUSLIFE) Dividend Will Be Reduced To ₹2.50
Zydus Lifesciences Limited ( NSE:ZYDUSLIFE ) has announced it will be reducing its dividend payable on the 9th of...
Indian (NIFTY) Pharma Industry Analysis
UpdatedMay 28, 2022
DataAggregated Company Financials
Companies144
- 7D-0.8%
- 3M-0.2%
- 1Y-10.1%
- YTD-11.7%
Last week, the Pharma industry hasn't moved much but Torrent Pharmaceuticals is up 10% in that time. As for the longer term, the industry has declined 10% in the last year. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Sun, 29 May 2022 | ₹9.6t | ₹2.7t | ₹312.9b | 20.7x |
| Tue, 26 Apr 2022 | ₹9.9t | ₹2.7t | ₹338.0b | 23.8x |
| Thu, 24 Mar 2022 | ₹10.0t | ₹2.7t | ₹337.9b | 24.3x |
| Sat, 19 Feb 2022 | ₹9.8t | ₹2.7t | ₹338.2b | 23x |
| Mon, 17 Jan 2022 | ₹10.7t | ₹2.7t | ₹361.8b | 26x |
| Wed, 15 Dec 2021 | ₹10.3t | ₹2.7t | ₹360.6b | 24.5x |
| Fri, 12 Nov 2021 | ₹10.4t | ₹2.6t | ₹361.9b | 22.5x |
| Sun, 10 Oct 2021 | ₹10.9t | ₹2.6t | ₹376.2b | 25.8x |
| Tue, 07 Sep 2021 | ₹10.9t | ₹2.6t | ₹374.6b | 24.2x |
| Thu, 05 Aug 2021 | ₹11.0t | ₹2.6t | ₹371.5b | 25.4x |
| Sun, 09 May 2021 | ₹9.9t | ₹2.5t | ₹332.3b | 20.5x |
| Wed, 10 Feb 2021 | ₹9.0t | ₹2.5t | ₹320.8b | 19.5x |
| Tue, 03 Nov 2020 | ₹8.0t | ₹2.4t | ₹234.1b | 21x |
| Fri, 07 Aug 2020 | ₹7.7t | ₹2.3t | ₹212.3b | 19.2x |
| Thu, 30 Apr 2020 | ₹6.6t | ₹2.3t | ₹223.9b | 16.4x |
| Sun, 02 Feb 2020 | ₹5.8t | ₹2.3t | ₹210.3b | 17.1x |
| Wed, 06 Nov 2019 | ₹5.5t | ₹2.3t | ₹234.5b | 16.2x |
| Sat, 10 Aug 2019 | ₹5.2t | ₹2.2t | ₹212.4b | 15.8x |
Median PE Ratio
17.2x
Current Industry PE
- Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 20.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 16% per year over the last three years.
- Revenues for these companies have grown 8.5% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Pharma compare with similar industries?
| IN Market | -0.87% | |
| Healthcare | -1.99% | |
| Pharma | -0.82% | |
| Pharma | -0.82% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 500420 Torrent Pharmaceuticals | ₹2.94k | 10.3% +₹46.6b | 8.2% | PS64x | |
| 500124 Dr. Reddy's Laboratories | ₹4.39k | 3.4% +₹24.2b | -15.5% | PS30.9x | |
| ZYDUSLIFE Zydus Lifesciences | ₹373.90 | 4.8% +₹17.5b | -39.8% | PS17.1x | |
| 506820 AstraZeneca Pharma India | ₹2.97k | 15.8% +₹10.1b | -21.5% | PS120.5x | |
| 539523 Alkem Laboratories | ₹3.04k | 1.4% +₹4.9b | 2.8% | PS22.1x |